Virdante Pharmaceuticals
Cambridge
About Virdante Pharmaceuticals
Virdante Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes drugs for autoimmune and inflammatory diseases. It offers antibody and Fc-fusion drugs to treat auto-immune diseases. The company was formerly known as Centaurus Pharmaceuticals and changed its name to Virdante Pharmaceuticals, Inc. in April, 2008. The company was founded in 2007 and is based in Cambridge, Massachusetts.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $60.1M
- Funding stage: M&A
- Last round: Series Unknown (Oct 2011)
- Website: virdante.com
- Phone: +1 617-300-8500
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/virdante-pharmaceuticals-2926482 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.